CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout

Chapter 2 - Neoplasms (C00-D49)»Benign neoplasms, except benign neuroendocrine tumors (D10-D36)»Melanocytic nevi (D22)

D22

Melanocytic nevi

Sub-codes (9)

  • D22.0 Melanocytic nevi of lip
  • D22.1 Melanocytic nevi of eyelid, including canthus
  • D22.2 Melanocytic nevi of ear and external auricular canal
  • D22.3 Melanocytic nevi of other and unspecified parts of face
  • D22.4 Melanocytic nevi of scalp and neck
  • D22.5 Melanocytic nevi of trunk
  • D22.6 Melanocytic nevi of upper limb, including shoulder
  • D22.7 Melanocytic nevi of lower limb, including hip
  • D22.9 Melanocytic nevi, unspecified

    1 indication for 1 drug

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.